Assyro AI

FDA Orange Book · active-ingredient family

Ciprofloxacin hydrochloride; hydrocortisone

Ciprofloxacin hydrochloride; hydrocortisone is approved as 1 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:CIPRO HC · NDA 020805

1

Brand (NDA)

1

Generics (ANDA)

0

Listed patents

1

Exclusivity periods

Brand (NDA) products · suspension/drops

ProductApplicantApplicationTEApproved
CIPRO HCRLDSANDOZNDA 020805ABFeb 10, 1998

Generic (ANDA) products (1)

ProductApplicantApplicationTEApproved
CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONECOSETTE PHARMS NCANDA 218273ABNov 10, 2025

Marketing exclusivity (1)

  • CGTFDA marketing exclusivity

    Jun 02, 2026

    17 d ago

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Ciprofloxacin hydrochloride; hydrocortisone — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.